Safety, Pharmacokinetics and Pharmacodynamics of DS-1040, in Combination with Thrombectomy, in Japanese Patients with Acute Ischemic Stroke
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-021-01112-8
Abstract: DS-1040 is a novel inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor that may have therapeutic potential in thromboembolic diseases, such as acute ischemic stroke (AIS) or pulmonary embolism. We undertook a Phase I… read more here.
Keywords: safety pharmacokinetics; acute ischemic; pharmacodynamics 1040; pharmacokinetics pharmacodynamics ... See more keywords